Phio Pharmaceuticals (PHIO) Treasury Shares (2012 - 2026)
Phio Pharmaceuticals' (PHIO) quarterly Treasury Shares came in at $831200.0 in Q1 2026, up 1070.7% YoY from $71000.0 in Q1 2025, and up 74.0% on a QoQ basis from $477700.0 in Q4 2025.
Phio Pharmaceuticals (PHIO) Treasury Shares (2012 - 2026) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 13 years of Treasury Shares data on file, last reported at $831200.0 in Q1 2026.
- Quarterly Treasury Shares rose 1070.7% year-over-year to $831200.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $831200.0 (up 1070.7% YoY) and the FY2025 annual result came in at $477700.0, up 572.82% from the prior year.
- Treasury Shares advanced to $831200.0 in Q1 2026, from $477700.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $886784.0 in Q1 2022 to a low of $1850.0 in Q2 2024.
- A 5-year average of $271155.2 and a median of $71000.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares plunged 97.46% — and 2025, when it surged 3737.84%.
- Tracing PHIO's Treasury Shares over 5 years: stood at $5257.0 in 2022, then grew by 5.1% to $5525.0 in 2023, then jumped by 1185.07% to $71000.0 in 2024, then jumped by 572.82% to $477700.0 in 2025, then surged by 74.0% to $831200.0 in 2026.
- The last three Treasury Shares figures came in at $831200.0 (Q1 2026), $477700.0 (Q4 2025), and $512800.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Phio Pharmaceuticals | 13.77 Mn | 13.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 792,200.00 |
| Jun 30, 2026 | 792,200.00 |
| Mar 31, 2026 | 831,200.00 |
| Mar 31, 2026 | 831,200.00 |
| Dec 31, 2025 | 477,700.00 |
| Dec 31, 2025 | 477,700.00 |
| Sep 30, 2025 | 512,800.00 |
| Sep 30, 2025 | 512,800.00 |
| Jun 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 71,000.00 |
| Mar 31, 2025 | 71,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 1,850.00 |
| Jun 30, 2024 | 1,850.00 |
| Mar 31, 2024 | 18,582.00 |
| Mar 31, 2024 | 18,582.00 |